product summary
Loading...
company name :
LifeSpan Biosciences
product type :
antibody
product name :
PathPlus™ GZMB / Granzyme B Antibody (N-Terminus) LS-B2783
catalog :
LS-B2783
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
immunohistochemistry - paraffin section
citations: 1
Reference
Limagne E, Thibaudin M, Nuttin L, Spill A, Derangère V, Fumet J, et al. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages. Cancer Immunol Res. 2019;7:1958-1969 pubmed publisher
image
image 1 :
LifeSpan Biosciences LS-B2783 image 1
Anti-GZMB / Granzyme B antibody IHC of human spleen. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 10 ug/ml.
product information
AntibodyID :
90038
AntibodyName :
LS-B2783
TargetSpecies :
Human
Host Species :
Rabbit
Product Name :
PathPlus™ GZMB / Granzyme B Antibody (N-Terminus) LS-B2783
ClonalityDesc :
Polyclonal
AntibodyModification :
Unconjugated
AntigenModification :
N-Terminus
PresentationDesc :
10 mM PBS, pH 7.4, 0.1% Sodium Azide, 1% BSA
ImmunogenType :
Synthetic peptide
ImmunogenDesc :
A synthetic peptide from N-Terminus of human Granzyme B
PurificationDesc :
Immunoaffinity purified
RecommendedStorageDesc :
Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
Gene :
GZMB / Granzyme B
StandardGeneSymbol :
GZMB
gene family :
Protease
Subfamily :
Serine S1
Reactivity :
Mouse, Rat, Human
Usage :
IHC-P (15 µg/ml)
ShortWebDescription :
Granzyme B antibody LS-B2783 is an unconjugated rabbit polyclonal antibody to Granzyme B (GZMB) (N-Terminus) from human. It is reactive with human, mouse and rat. Validated for IHC. Cited in 1 publication.
UsageText :
Immunohistochemistry: LS-B2783 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working dilution for LS-B2783 was determined to be 1:100.
Synonyms :
GZMB, CCPI, CGL-1, Cathepsin G-like 1, CSP-B, CTLA-1, CTLA1, CGL1, CSPB, Fragmentin 2, GRB, HLP, Human lymphocyte protein, Fragmentin-2, SECT, Lymphocyte protease, T-cell serine protease 1-3E, C11, CTSGL1, Cytotoxic serine protease B, Granzyme B, Granzyme-2
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
CustomerSupport@lsbio.com
https://www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.